Clinical trials
Terminated Cholangiocarcinoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| QED Therapeutics, a BridgeBio company | 2 |
| Amgen | 1 |
| Concordia Laboratories Inc. | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Elevation Oncology | 1 |
| Halozyme Therapeutics | 1 |
| Kinnate Biopharma | 1 |
| NuCana plc | 1 |
| PCI Biotech AS | 1 |
| Seoul National University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 11 |
| Bile Duct Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Gallbladder Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Adenocarcinoma | 1 |
| Adenocarcinoma of Lung | 1 |
| Breast Neoplasms | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.